Boehringer Ingelheim Pharmaceuticals, Inc. recalls
Every recall we track for Boehringer Ingelheim Pharmaceuticals, Inc. — 13 in all, from 2016–2026 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
Recalls from Boehringer Ingelheim Pharmaceuticals, Inc. peaked in 2020 (3); 11 since 2017.
All FDA recall records for Boehringer Ingelheim Pharmaceuticals, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 2 | 0 | 2 |
| 2018 | 0 | 0 | 1 | 1 | 2 |
| 2019 | 0 | 0 | 1 | 0 | 1 |
| 2020 | 0 | 0 | 2 | 1 | 3 |
| 2021 | 0 | 0 | 1 | 0 | 1 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 1 | 0 | 1 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 1 | 0 | 1 |
Boehringer Ingelheim Pharmaceuticals, Inc. recalls before 2017
Recalls on record by year.
Most common reasons for Boehringer Ingelheim Pharmaceuticals, Inc. recalls
What to do if you have a recalled Boehringer Ingelheim Pharmaceuticals, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Boehringer Ingelheim Pharmaceuticals, Inc. recalls
10 shown- Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per
Boehringer Ingelheim recalls Synjardy XR tablets due to potential contamination from incorrect detergent use during production. Affected lots may have unsafe levels of impurities.
Boehringer IngelheimJun 12, 2026 - Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90)
Boehringer Ingelheim recalls JARDIANCE 25mg tablets due to potential label mix-up. Affected lots E61835 expire June 2025. Consumers should check packaging for correct labeling.
Boehringer IngelheimMar 9, 2023 - Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by:
Boehringer Ingelheim recalls 80mg Micardis tablets (NDC 0597-0041-37) due to subpotent drug content. Patients may not get full treatment effect. Contact for return instructions.
Boehringer IngelheimMay 4, 2021 - UnratedDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim
Boehringer Ingelheim recalls specific lots of Catapres 0.1 mg tablets after an extraneous peak was observed during dissolution testing.
Boehringer IngelheimOct 5, 2020 - Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only,
Boehringer Ingelheim recalls Mirapex 1mg tablets due to low weight detected in stability testing. Affected lots may have inconsistent dosing.
Boehringer IngelheimMar 7, 2019 - UnratedDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim
Boehringer Ingelheim recalls Catapres .2 0.2mg 100-count bottles due to failed dissolution specifications in stability testing. No remedy provided in official notice.
Boehringer IngelheimOct 22, 2018 - Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by:
Boehringer Ingelheim recalls Synjardy (empagliflozin and metformin) tablets due to cross contamination risk. This prescription medication (5mg/1000mg) is in 180-count bottles with specific lot numbers.
Boehringer IngelheimSep 4, 2018 - Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) per box, Rx
Boehringer Ingelheim recalls SPIRIVA HandiHaler inhalers with failed stability specifications. This may affect safety and effectiveness of the medication.
Boehringer IngelheimDec 14, 2017 - Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI)
Boehringer Ingelheim recalls Mobic 15mg tablets with incorrect or missing package inserts. Affected lots may not have proper instructions for safe use.
Boehringer IngelheimSep 22, 2017 - Lower riskDrug
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI)
Boehringer Ingelheim recalls 75mg Persantine tablets where 50mg tablets were mistakenly included. This could cause incorrect dosing if taken.
Boehringer IngelheimOct 6, 2016
Boehringer Ingelheim Pharmaceuticals, Inc. recall questions
How many recalls has Boehringer Ingelheim Pharmaceuticals, Inc. had?
13 recalls from Boehringer Ingelheim Pharmaceuticals, Inc. are on record with U.S. safety agencies, from 2016–2026.
What is the most recent Boehringer Ingelheim Pharmaceuticals, Inc. recall?
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per, dated Jun 12, 2026. Every Boehringer Ingelheim Pharmaceuticals, Inc. recall is listed on this page, newest first.
Why are Boehringer Ingelheim Pharmaceuticals, Inc. products recalled?
The most common reasons on record: An extraneous peak was observed for dissolution testing. (3).
What should I do if I have a recalled Boehringer Ingelheim Pharmaceuticals, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Boehringer Ingelheim Pharmaceuticals, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.